Q: Check everything and can we prescribe folvit in IDA A: Now I have enough information to give a comprehensive review. Let me compile the analysis. --- Discharge Summary Review — R. Manisha, 29F Patient Summary Field Details ------ Name R. Manisha, 29 yrs, Female Admission 26/03/2026 → Discharge 08/04/2026 13 days Diagnosis Severe Anemia Iron Deficiency Anemia — IDA Presenting complaint Missed periods × 2 months, after taking Tab. Regestran Co-morbidities None no HTN, T2DM, Thyroid disease, CAD --- Examination Findings - General: Pallor present, afebrile - CVS: S1 S2 heard, no murmur - RS: NVBS, BAE clear - P/A: Soft, non-tender - CNS: No focal neurological deficits - BP: 100/60 mmHg PR: 101 bpm - PICCLE: Only Pallor + noted, rest negative --- Investigation Review Date Hb g/dL WBC /mm³ Platelets ------------ 28/03/26 4.2 3,820 4.6 lakhs 31/03/26 5.4 3,800 4.0 lakhs 03/04/26 8.8 5,100 2 lakhs 06/04/26 10.3 4,000 1.8 lakhs - LFT, RFT, Electrolytes: WNL - Sr. Ca²⁺: 8.5 mg/dL low-normal; explains Ca gluconate supplementation - Stool for occult blood: Negative on 6/4 & 7/4 rules out GI blood loss - Trend: Hb improved from 4.2 → 10.3 g/dL with transfusion + IV iron — good response --- Treatment Given In-Hospital Drug Route/Dose Notes ------------ 1 2× PRBC transfusion IV On 1/4 & 2/4/26 2 Inj. Ca Gluconate 1 amp in 100mL NS, IV TID × 5d For low-normal calcium 3 Inj. Orofer-S 200mg IV, alternate day × 6 doses IV iron sucrose 4 Inj. Pan 40mg IV OD Proton pump inhibitor 5 Inj. Zofer 4mg IV OD Antiemetic ondansetron 6 Tab. Folvit 5mg PO, BID Folic acid supplement 7 Cap. Berozinc PO OD Zinc supplement 8 Cap. Uprise-D3 60K PO OD × 7d Vitamin D3 --- Treatment Advised at Discharge 1. Tab. Shelcal — PO OD 0-1-0 × 15 days → Calcium + Vitamin D3 2. Tab. Uprise 60K — PO OD 0-1-0 × 15 days → Vitamin D3 --- ⚠️ Notable Observations 1. No oral iron prescribed at discharge — This is a significant gap. After IV Orofer-S in-hospital, oral iron e.g., ferrous sulfate/ferrous ascorbate should be continued at discharge to replenish stores. Hb of 10.3 at discharge is still sub-optimal for a 29-year-old woman normal ≥12 g/dL. 2. No Folvit at discharge — Folvit folic acid 5mg was given in-hospital but not continued at discharge. See below. 3. Cause of IDA not fully addressed — Missed periods due to Regestran norethisterone, used to delay/postpone periods plus stool occult blood negative. Underlying cause of iron depletion diet, menstrual history, absorption should be investigated outpatient. 4. Platelet drop 4.6L → 1.8L — worth monitoring at follow-up. --- Can Folvit Be Prescribed in IDA? Folvit = Folic acid 5mg tablet Short answer: Yes, but it is not a primary treatment for IDA and must be used judiciously. Rationale: Aspect Detail ------ IDA is a microcytic, hypochromic anemia caused by iron deficiency — the primary treatment is iron oral or IV, not folic acid Folic acid deficiency causes megaloblastic/macrocytic anemia — a separate condition Why it may still be given in IDA: In nutritionally deficient patients especially young women in India, mixed deficiency iron + folate is common. Folvit is often co-prescribed prophylactically Pharmacology textbook note: "Megaloblastic anemia results from a deficiency in vitamin B12 and/or folic acid. Empiric treatment should consist of a combination of folic acid..." — Lippincott Pharmacology Risk of folic acid alone in B12 deficiency: Giving high-dose folic acid without checking B12 can mask B12 deficiency and allow subacute combined degeneration of the spinal cord to progress — this is a key caution In this specific patient: - She received Folvit 5mg BID in-hospital — appropriate as supportive therapy given severe nutritional anemia - B12 was not documented in the investigations — ideally should be checked - Since stool occult blood is negative and she's a young woman, dietary deficiency of multiple nutrients iron + folate ± B12 is very likely - Continuing Folvit 5mg OD at discharge is reasonable and safe, provided B12 deficiency has been considered/excluded --- Summary Recommendation ✅ Folvit can be prescribed in IDA as adjunct therapy — especially in nutritionally deficient young women with possible mixed deficiency ⚠️ Primary treatment oral iron is missing from the discharge prescription — this needs to be added e.g., Tab. Ferrous Ascorbate 100mg OD or Ferrous Sulfate 200mg OD ⚠️ Check serum B12 before long-term high-dose folic acid ✅ Follow-up Hb in 4–6 weeks to confirm continued rise toward ≥12 g/dL
